Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0ZV1T
|
||||
Former ID |
DNC007284
|
||||
Drug Name |
N-(2,6-diphenylpyrimidin-4-yl)-2-ethylbutyramide
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [527331] | ||
Structure |
Download2D MOL |
||||
Formula |
C22H23N3O
|
||||
Canonical SMILES |
CCC(CC)C(=O)NC1=NC(=NC(=C1)C2=CC=CC=C2)C3=CC=CC=C3
|
||||
InChI |
1S/C22H23N3O/c1-3-16(4-2)22(26)25-20-15-19(17-11-7-5-8-12-17)23-21(24-20)18-13-9-6-10-14-18/h5-16H,3-4H2,1-2H3,(H,23,24,25,26)
|
||||
InChIKey |
ZMYSFVQFZFGCMP-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Adenosine A2a receptor | Target Info | Inhibitor | [527331] | |
Adenosine A1 receptor | Target Info | Inhibitor | [527331] | ||
NetPath Pathway | TCR Signaling Pathway | ||||
RANKL Signaling Pathway | |||||
Pathway Interaction Database | HIF-2-alpha transcription factor network | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.